Skip to content

Electronic Compliance Monitoring in Opioid Substitution Treatment

Electronic Compliance Monitoring in Opioid Substitution Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01182402
Acronym
EHSO
Enrollment
37
Registered
2010-08-16
Start date
2010-09-30
Completion date
2011-02-28
Last updated
2011-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opiate Dependence

Keywords

opiate dependence, substitution treatment, unsupervised dosing, monitoring

Brief summary

The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.

Interventions

Patients get all their unsupervised substitution medication doses in electronic monitoring devices during the study. Daily dose of the drug is possible to get from the device in given time points and in the meantime device is locked.

Sponsors

University of Eastern Finland
CollaboratorOTHER
Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* opiate dependence F11.22 according to ICD-10 * Suboxone treatment * the duration of substitution treatment before study at least one month * stable medication dose

Exclusion criteria

* unstable situation in life according to treatment staff's opinions

Design outcomes

Primary

MeasureTime frameDescription
The effectiveness of treatment (Treatment Outcomes Profile TOP)Every two months.Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.

Secondary

MeasureTime frameDescription
Patients´opinions about the treatment.Once when the study phase ends (after four months).Questionnaire designed for this study to explore patients' opinions on the compliance monitoring and it's effect on their treatment and abuse and/or diversion of medications.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026